Tranexamic Acid IV Dosing for 49kg Patient
For a 49kg patient, administer tranexamic acid 490mg (10 mg/kg) as an IV bolus, followed by a maintenance infusion of 49-245mg/hour (1-5 mg/kg/hour), with the specific rate and duration determined by the clinical indication.
Weight-Based Calculation
- Loading dose: 10 mg/kg × 49kg = 490mg IV bolus 1
- Maintenance infusion: 1-5 mg/kg/hour × 49kg = 49-245mg/hour 1
- The FDA-approved dosing for hemophilia patients is 10 mg/kg actual body weight as a single dose, which would be 490mg for this patient 2
Clinical Context-Specific Dosing
For Trauma/Major Bleeding (CRASH-2 Protocol)
- Loading dose: 1g IV over 10 minutes (regardless of weight) 1
- Maintenance: 1g IV infusion over 8 hours 1
- Must be administered within 3 hours of injury for mortality benefit 1
- This fixed-dose regimen from the landmark CRASH-2 trial supersedes weight-based dosing in trauma settings, as it demonstrated a 9% relative risk reduction in all-cause mortality 1
For Cardiac Surgery
- Loading dose: 490mg (10 mg/kg) IV bolus 1
- Maintenance: 49mg/hour (1 mg/kg/hour) continuous infusion 1
- Maximum total dose should not exceed 4,900mg (100 mg/kg) to avoid seizure risk 1, 3
- The Horrow regimen (10 mg/kg bolus + 1 mg/kg/hour) achieves therapeutic plasma levels of 10 μg/mL required to inhibit fibrinolysis 1
For Cirrhosis-Related Bleeding
- Fixed dose: 1g IV every 6 hours 1
- This is not weight-adjusted and represents a rescue measure for active bleeding 1
Critical Administration Details
Infusion Rate
- Infuse no faster than 1 mL/minute (100mg/minute) to avoid hypotension 2
- For the 490mg loading dose, this means infusion over at least 5 minutes 2
Renal Dose Adjustments (Essential)
For serum creatinine 1.36-2.83 mg/dL:
- 490mg (10 mg/kg) IV twice daily only 2
For serum creatinine 2.83-5.66 mg/dL:
- 490mg (10 mg/kg) IV once daily only 2
For serum creatinine >5.66 mg/dL:
490mg (10 mg/kg) IV every 48 hours OR 245mg (5 mg/kg) every 24 hours 2
Failure to adjust for renal dysfunction leads to drug accumulation and increased risk of seizures and neurotoxicity, as 90% is renally excreted 2, 4
Safety Considerations and Contraindications
Absolute Contraindications
- Active intravascular clotting or thrombosis 2
- Subarachnoid hemorrhage (risk of cerebral edema and infarction) 2
- Known hypersensitivity to tranexamic acid 2
Avoid Concomitant Use With
- Hormonal contraceptives (increased thrombotic risk) 2
- Factor IX concentrates 2
- Anti-inhibitor coagulant concentrates 2
- These combinations significantly increase thromboembolic risk 2
Seizure Risk
- Doses exceeding 100 mg/kg total are associated with significantly increased seizure risk, particularly in cardiac surgery patients over 50 years 1, 3
- For this 49kg patient, the maximum safe total dose is 4,900mg 1, 3
- Tranexamic acid is an independent predictor of postoperative seizures with odds ratio of 14.3 3
Duration of Therapy
- Continue infusion until bleeding is adequately controlled 1
- For trauma: 8-hour infusion protocol per CRASH-2 1
- For dental procedures in hemophilia: may continue 10 mg/kg 3-4 times daily for 2-8 days post-procedure 2
- Discontinue as soon as hemostasis is achieved to minimize thrombotic complications 1
Common Pitfalls to Avoid
- Never administer intrathecally - serious adverse reactions including seizures and cardiac arrhythmias have occurred with incorrect route 2
- Do not mix with penicillin-containing solutions - tranexamic acid is a synthetic amino acid incompatible with penicillin 2
- Do not mix with blood products - mix only with electrolyte, carbohydrate, amino acid, or dextran solutions 2
- Assess renal function before every dose - even mild renal impairment requires dose reduction 2, 4
- In trauma, do not delay for weight calculation - use the fixed 1g + 1g protocol if weight unknown 1